|
 |
AbarelixThis page contains recent news articles, when available, and an overview of Abarelix but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Abarelix (when available) Used in the palliative treatment of advanced prostate cancer. Abarelix is a luteinizing hormone agonist that results in suppression of testicular or follicular steroidogenesis. For palliative treatment of advanced prostate cancer Mechanism Of Action: Abarelix binds to the gonadotropin releasing hormone receptor and acts as a potent inhibitor of gonadotropin secretion. News Articles on Abarelix Ferring's degarelix offers exciting option for prostate cancer - Mar 28, 2008 Significantly, the drug was not been seen to cause dangerous systemic reactions of the type that have dogged the earlier GnRH blocker drug, abarelix, Pharma Times (subscription), Metastatic Carcinoma of the Long Bones - Nov 13, 2007 ...goserelin [Zoladex], triptorelin [Trelstar Depot]); LH-RH antagonists (eg, abarelix [Plenaxis, not available in the United States]); and antiandrogens AAFP News Now Doctors write 300000 prescriptions for drug - Sep 28, 2007 However, the drug abarelix (Plenaxis) can trigger a life-threatening allergic reaction in some men, so it is used only when other forms of therapy are not Globe and Mail, Research and Markets : Sales of Abarelix For the Treatment of ... - Jan 15, 2007 PharmaLive.com (press release),Abarelix was approved in November 2003 for the palliative treatment of men with advanced symptomatic prostate cancer. In May 2004 docetaxel was approved for There Are Currently No Less Than 220 Emerging Therapeutics ... - Jan 16, 2007 PharmaLive.com (press release),Abarelix was approved in November 2003 for the palliative treatment of men with advanced symptomatic prostate cancer. In May 2004 docetaxel was approved for Brand Names/Synonyms: Abarelix is also known by the following brand names and/or synonymsPlenaxis; Plenaxis (Praecis Pharmaceuticals) Drug Category: Abarelix is categorized under the following by the FDA: Antineoplastic Agents; Anti-Testosterone Agents Dosage Forms: Not Available Absorption: Not Available Interactions: Not Available Chemical IUPAC Name: acetyl-D-ß-naphthylalanyl- D-4-chlorophenylalanyl-D-3-pyridylalanyl-L-seryl-L- N-methyl-tyrosyl-D-asparagyl-L-leucyl-L-N(e )-isopropyl-lysyl-L-prolyl-D-alanyl-amide : |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines mongabay.com
COPYRIGHT 2007 MONGABAY.COM |